Evaluation of the Activity of Drugs Containing Human Cell Lines: Promising Approaches and Requirements of Regulatory Bodies
This article analyzes the latest requirements of the US and European regulatory authorities for the assessment of the activity of preparations containing human cell lines (biomedical cell product analogues); it gives a review of methods and approaches to the assessment of activity used by manufactur...
Saved in:
| Main Authors: | A. A. Chaplenko, E. V. Melnikova, O. A. Rachinskaya, Yu. V. Olefir |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
International Practice of Storing Human Cell Lines Intended for Clinical Use
by: O. A. Rachinskaya, et al.
Published: (2018-12-01) -
Evaluation of Cell Line Identity Using RTCA Profiling for Quality Control of Products Containing Viable Human Cells
by: M. A. Vodyakova, et al.
Published: (2023-09-01) -
Comparative Research on Regulatory Requirements of Radiotherapy Equipment Across Countries
by: Chao SUN, et al.
Published: (2025-01-01) -
Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
by: E. V. Melnikova, et al.
Published: (2020-07-01) -
Use of Cytogenetic Analysis Methods for Assessing the Quality of Cell Lines in Biomedical Cell Products
by: O. A. Rachinskaya, et al.
Published: (2018-03-01)